Dry Eye Disease Study With Brimonidine

NCT03418727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: Brimonidine
DRUG: Brimonidine Mono Therapy
DRUG: sodium carboxymethylcellulose
DRUG: Corticosteroid Eye Drop

Sponsor

Ocugen